MED

Medifast, Inc. (MED) ESG Analysis Analysis (2026)

Invetso Score: 6.5/10 — Balanced · Last Updated: 2026-09-01

Environmental

Low reported R&D intensity versus diversified healthcare peers suggests a limited environmental innovation footprint, though this is less material than in manufacturing-heavy sectors.

No provided evidence indicates elevated emissions, waste, or resource-use exposure, leaving MED broadly in line with peers on direct operational environmental risk.

Capital structure metrics do not materially inform environmental positioning, so relative ESG assessment remains driven by limited disclosed environmental initiatives and sector norms.

Absent filing-based disclosure on climate targets or environmental incidents, MED appears neither advantaged nor structurally disadvantaged versus peers on environmental management.

Social

Moderate stock-based compensation intensity can support employee retention and alignment, but it also signals dilution pressure that peers may manage more efficiently.

High gross margin is not an ESG factor by itself, yet it can indicate capacity to sustain workforce and service investments relative to weaker peers.

No provided evidence of labor controversies, patient-safety incidents, or access-to-care disclosures limits confidence, leaving MED near peer median on social risk management.

The absence of disclosed social metrics such as turnover, safety, or community access prevents a stronger relative score despite no visible peer-disadvantaging controversy.

Governance

Low debt-to-equity suggests conservative balance-sheet governance relative to peers, reducing creditor pressure and supporting board flexibility over the medium term.

Very high net debt to EBITDA appears anomalous and may reflect data quality or earnings volatility, but the low leverage ratio still points to manageable capital discipline.

Stock-based compensation at 2.1% of revenue is moderate, indicating compensation governance that is not obviously more aggressive than peers.

No provided evidence of major governance controversies, restatements, or board failures supports a stronger-than-average governance assessment versus peers.

Overall Score

MED appears broadly in line with peers overall, with governance relatively stronger than environmental and social positioning, which remain closer to peer median.

Score Driver: Conservative Leverage And No Disclosed Governance Controversy Outweigh Limited Environmental And Social Disclosure Advantages.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Medifast, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →